ARZNEIMITTELABGABEMECHANISMUS

Patent europeic · EP3740264 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3740264
Numer da la dumonda
EP19703535
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
17-01-2019
Publitgà
25-11-2020
Concedì
08-04-2026
La protecziun finescha il pli tard
16-01-2039
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61M 5/142 (2006.01)
A61M 5/145 (2006.01)
A61M 5/315 (2006.01)
Prioritad
US 201862618288 P 17.01.2018
Dumonda PCT
PCT/US2019/013905 17.01.2019
Publicaziun PCT
WO2019/143753 25.07.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 08-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.04.2026

Partidas

Possessur

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

Inventur

DUTTA RAY, Sudeshna

Thousand Oaks, CA 91361, US

GIBSON, Scott R.

Granada Hill, CA 91344, US

GROSZMANN, Daniel Eduardo

Belmont, MA 02478, US

MOJARRAD, Mehran

Thousand Oaks, CA 91362, US

DEES, Robert Allen

San Diego, CA 92131, US

JOHNSON, Jonathan Dean

San Marcos, CA 92078, US

MURCIA, Antonio S.

Oceanside, CA 92054, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.